back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-13 19:31 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Holder: Elixir Holding Company Ltd. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$14,875
+29,750 vol $0.50 each |
29,750 | |
| Filed 2025-11-13 19:30 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Holder: Elixir Holding Company Ltd. (Indirect Ownership)
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-13 19:28 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Holder: Elixir Holding Company Ltd. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$24,990
+59,500 vol $0.42 each |
559,500 | |
| Filed 2025-11-13 19:27 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
15 - Acquisition or disposition under a prospectus
|
$17,877
+35,755 vol $0.50 each |
35,755 | |
| Filed 2025-11-13 19:26 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Warrants Expiring 24 mos from Nov 12, 2025
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-13 19:25 Tx date 2025-11-12 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$30,034
+71,510 vol $0.42 each |
71,510 | |
| Filed 2025-11-13 19:24 Tx date 2024-06-06 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-07-02 17:12 Tx date 2025-07-01 |
$PCRX
PharmaCorp Rx Inc. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,999
+52,083 vol $0.48 each |
73,740 | |
| Filed 2024-07-18 15:39 Tx date 2024-07-18 |
$PTN
Proton Capital Corp. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$8,662
+21,657 vol $0.40 each |
21,657 | |
| Filed 2024-07-18 15:38 Tx date 2024-06-06 |
$PTN
Proton Capital Corp. |
Hladun, Grant Warren
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-06-13 10:23 Tx date 2024-06-06 |
$PTN
Proton Capital Corp. |
Hladun, Grant Warren
4 - Director of Issuer
Holder: Grant Hladun - TFSA (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,000
+250,000 vol $0.40 each |
250,000 | |
| Filed 2024-06-13 10:23 Tx date 2024-06-06 |
$PTN
Proton Capital Corp. |
Hladun, Grant Warren
4 - Director of Issuer
Holder: Grant Hladun - TFSA (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-06-13 10:21 Tx date 2024-06-06 |
$PTN
Proton Capital Corp. |
Hladun, Grant Warren
4 - Director of Issuer
Holder: Elixir Holding Company Ltd. (Indirect Ownership)
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$200,000
+500,000 vol $0.40 each |
500,000 | |
| Filed 2024-06-13 10:19 Tx date 2024-06-06 |
$PTN
Proton Capital Corp. |
Hladun, Grant Warren
4 - Director of Issuer
Holder: Elixir Holding Company Ltd. (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|